A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson's disease

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Troeung, Lakkhina ^a   Egan, Sarah J ^a   Gasson, Natalie ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Anxiety; Cognitive behavioural therapy; Depression; Parkinson's disease; Psychotherapy; Randomised controlled trial; Treatment

Indexed keywords

AGED; ANXIETY; AUSTRALIA; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; MIDDLE AGED; NEW ZEALAND; PARKINSON DISEASE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANXIETY; AUSTRALIA; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PARKINSON DISEASE; TREATMENT OUTCOME; WAITING LISTS;

EID: 84892876988     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-19     Document Type: Article

References (47)

1. Weintraub D, Burn DJ. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011, 26:1022-1031. 10.1002/mds.23664, 3513835, 21626547.
2. Dissanayaka NN, Sellbach A, Matheson S, et al. Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2010, 25:838-845. 10.1002/mds.22833, 20461800.
3. Behar M, Srivastava AK, Pandey RM. Quality of life in patients with Parkinson's disease. Parkinsonism Relat Disord 2005, 11:221-226.
4. Chung TH, Deane KHO, Ghazi-Noori S, Rickards H, Clarke CE. Systematic review of antidepressant therapies in Parkinson's disease. Parkinsonism Related D 2003, 10:59-65.
5. Skapinakis P, Bakola E, Salanti G, Lewis G, Kyritisis P, Mavreas V. Efficacy acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol 2010, 10:49-60. 10.1186/1471-2377-10-49, 2903535, 20565960.
6. Troeung L, Egan SJ, Gasson N. A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease. PLoS One 2013, 8(11):e79510. 10.1371/journal.pone.0079510, 3827386, 24236141.
7. Barone P, Poewe W, Albrecht S, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010, 9:575-580.
8. Moralez Da Silva T, Munhoz RP, Alvarez C, et al. Depression in Parkinson's disease: A double-blind, randomized, placebo controlled pilot study of omega-3 fatty-acid supplementation. J Aff Disord 2008, 111:351-359.
9. Chen R. Repetitive transcranial magnetic stimulation as treatment for depression in Parkinson's disease. Mov Disord 2010, 25:2272-2273. 10.1002/mds.23266, 20740486.
10. Dobkin DR, Menza M, Allen LA, et al. Cognitive behaviour therapy for depression in Parkinson's disease: a randomized controlled trial. Am J Psychiatry 2011, 168:1066-1074. 3186855, 21676990.
11. Black KJ. A new(old) treatment option for depression in Parkinson's disease. Am J Psychiatry 2011, 168:1015-1016. 10.1176/appi.ajp.2011.11071124, 21969043.
12. Dobkin RD, Allen LA, Menza M. A cognitive-behavioral treatment package for depression in Parkinson's disease. Psychosomatics 2006, 47:259-263. 10.1176/appi.psy.47.3.259, 16684945.
13. Dobkin RD, Allen LA, Menza M. Cognitive-behavioural therapy for depression in Parkinson's disease: a pilot study. Mov Disord 2007, 22:946-952. 10.1002/mds.21455, 17377926.
14. Farabaugh A, Locascio JJ, Yap L, et al. Cognitive-behavioural therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics 2010, 51:124-129.
15. Feeney F, Egan S, Gasson N. Treatment of depression and anxiety in Parkinson's disease: a pilot study using group cognitive behavioural therapy. Clin Psychol 2005, 9:31-38.
16. Gupta R. Treatment of depression in an elderly Asian Indian male: a cognitive behavioural approach. Clin Geronotologist 2000, 22:87-90.
17. Heinrichs N, Hoffman EC, Hofmann SG. Cognitive-behavioural treatment for social phobia in Parkinson's disease: a single case-study. Cogn Behav Pract 2001, 8:328-335. 10.1016/S1077-7229(01)80005-5, 1476697, 16770438.
18. Laidlaw K, Thompson LW, Dick-Siskin L, Gallagher-Thompson D. Cognitive-Behaviour Therapy with Older People 2003, Chichester, England: John Wiley & Sons.
19. Mohlman J, Reef DH, Chazin D, Ong D, Georgescu B, Tiu J, Dobkin RD. A novel approach to treating anxiety and enhancing executive skills in an older adult with Parkinson's disease. Clin Case Stud 2010, 8:74-90.
20. Thompson LW, Powers DV, Coon DW, Takagi K, McKibbin C, Gallagher-Thompson D. Older adults. Cognitive behavioural group therapy: For specific problems and populations 2000, Washington DC: American Psychological Association, White JR, Freeman AS.
21. A'Campo LEI, Wekking EM, Spliethoff-Kamminga NGA, Le Cessie S, Roos RAC. The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers. Parkinsonism Relat Disord 2010, 16:89-95. 10.1016/j.parkreldis.2009.07.009, 19674927.
22. Macht M, Gerlich C, Ellgring H, Schradi M, Rusinol AB, Crespo M, et al. Patient education in Parkinson's disease: formative evaluation of a standardized program in seven European countries. Patient Educ Couns 2007, 65:245-252. 10.1016/j.pec.2006.08.005, 16965885.
23. Simons G, Thompson SBN, Pasqualini S. An innovative education programme for people with Parkinson's disease and their carers. Parkinsonism Relat Disord 2006, 12:478-485. 10.1016/j.parkreldis.2006.05.003, 16781881.
24. Husaini BA, Cummings S, Kilbourne B, Roback H, Sherkat D, Levine R, Cain VA. Group therapy for depressed elderly woman. Int J Group Psychother 2004, 54:295-319. 10.1521/ijgp.54.3.295.40340, 15253507.
25. Glass TA, Mendes De Leon CF, Bassuk SS, Berkman L. Social engagement and depressive symptoms in late life: longitudinal findings. J Aging Health 2006, 18:604-628. 10.1177/0898264306291017, 16835392.
26. Lewinsohn PM, Clarke GN. Psychosocial treatments for adolescent depression. Clin Psychol Rev 1999, 19:329-342. 10.1016/S0272-7358(98)00055-5, 10097874.
27. Fischer DJ, Himle JA, Hanna GL. Group behavioral therapy for adolescents with obsessive-compulsive disorder: preliminary outcomes. Res Social Work Prac 1998, 8:629-636.
28. Tucker M, Oei TPS. Is group more cost effective than individual cognitive behaviour therapy? The evidence is not solid yet. Behav Cogn Psychother 2007, 35:77-91.
29. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trial. BMJ 2010, 340:c869. 10.1136/bmj.c869, 2844943, 20332511.
30. American Psychiatric Association Diagnostic and statistical manual of mental disorders (4th ed., text rev.) 2000, Washington, DC: American Psychiatric Association, American Psychiatric Association.
31. First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders 2002, New York: Biometrics Research.
32. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsy Neuropsy Be 1988, 1:111-117.
33. Sheehan DV, Janavs J, Baker R, Harnett-Sheehan K, Knapp E, Sheehan M. Mini International Neuropsychiatric Interview 1994, Tampa: University of South Florida.
34. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan K, Janavs J, Dunbar G. The M.I.N.I. International Neuropsychiatric Interview (M.I.N.I.) A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997, 12:224-231.
35. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the Beck depression and anxiety inventories. Behav Res Ther 1995, 33:335-343. 10.1016/0005-7967(94)00075-U, 7726811.
36. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998, 245:S10-S14. 10.1007/PL00007730, 9617716.
37. Beck AT, Brown G, Steer RA, Eidelson JI, Riskin JH. Differentiating anxiety and depression: a test of the cognitive content-specificity hypothesis. J Abnorm Psychol 1987, 96:179-183.
38. Nathan P, Rees C, Smith L. Mood Management Course 2001, Perth: The West Australian Institute for Psychotherapy Research.
39. Verbeke G, Molenbergs G. Linear Mixed Models for Longitudinal Data 2000, New York: Springer-Verlag.
40. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991, 59:12-19.
41. Veazey C, Cook KF, Stanley M, Lai EC, Kunik ME. Telephone-administered cognitive behavioural therapy: a case study of anxiety and depression in Parkinson's disease. J Clin Psychol Med Settings 2009, 16:243-253. 10.1007/s10880-009-9167-6, 19404724.
42. Rachman S. Rapid and not-so-rapid responses to cognitive behavioural therapy. Clin Psychol-Sci PR 1999, 6:293-294.
43. National Institute of Health and Clinical Excellence Depression. The NICE guideline on the treatment management of depression in adults. Updated Version 2010, Great Britain: British Psychological Society and the Royal College of Psychiatrists, National Institute of Health and Clinical Excellence.
44. Leentjens AFG, Vreeling FW, Luijckx GJ, Verhey FRJ. SSRIs in the treatment of depression in Parkinson's disease. Int J Geriatr Psychiatry 2003, 18:552-554. 10.1002/gps.865, 12789682.
45. Qureshi SU, Amspoker AB, Calleo JS, Kunik ME, Marsh L. Anxiety disorders, physical illnesses and health care utilization in older male veterans with Parkinson disease and comorbid depression. J Geriatr Psychiatry Neurol 2012, 25:233-239. 10.1177/0891988712466458, 23197499.
46. Dobkin RD, Rubino JT, Friedman J, Allen LA, Gara MA, Menza M. Barriers to mental health care utilization in Parkinson's disease. J Geriatr Psychiatry Neurol 2013, 26:105-116. 10.1177/0891988713481269, 23589410.
47. Mohr DC, Spring B, Freedland KE, et al. The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom 2009, 78:275-284. 10.1159/000228248, 19602916.